NN

Nirendra Nath Halder

Active Director Designated Partner DIN 11506807
DIN 11506807 First appointment Jan 2026 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nirendra Nath Halder

Data last updated:

Nirendra Nath Halder is a Designated Partner at Trinetra Biosciences Llp (since 2026). The company operates in Biotechnology.

DIN 11506807
Primary Designation Designated Partner
Industry Biotechnology
First Appointment 27 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Jan 20262026Active

Board colleagues of Nirendra Nath Halder

NameDINCompanyDesignation
Kalyani Haldar11506808Trinetra Biosciences LlpDesignated Partner
Nirmalya Halder09233978Trinetra Biosciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Trinetra Biosciences Llp
Premium access

Shareholding and investment profile for Nirendra Nath Halder

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirendra Nath Halder

Nirendra Nath Halder currently holds 1 directorship: Trinetra Biosciences Llp (Designated Partner, since 27 Jan 2026).

Nirendra Nath Halder was first appointed on 27 Jan 2026 as Designated Partner at Trinetra Biosciences Llp.

The current boards of Nirendra Nath Halder's companies include Kalyani Haldar (Trinetra Biosciences Llp), Nirmalya Halder (Trinetra Biosciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available